Rubicon Research (NSE:RUBICON) Enterprise Value: ₹236,674 Mil (As of Jul. 19, 2026) ***

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:RUBICON Rubicon Research Ltd NSE:RUBICON
18 GF Score
Price ₹1,439.60
! 3 Warning Signs
View Full Analysis

What is Rubicon Research Enterprise Value?

Rubicon Research NSE:RUBICON +1.45% 18 Enterprise Value is ₹236,674 Mil as of Jul. 19, 2026. GuruFocus rates NSE:RUBICON with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Rubicon Research's Enterprise Value is ₹236,674 Mil. Rubicon Research's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2,776 Mil. Therefore, Rubicon Research's EV-to-EBIT ratio for today is 85.27.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Rubicon Research's Enterprise Value is ₹236,674 Mil. Rubicon Research's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,110 Mil. Therefore, Rubicon Research's EV-to-EBITDA ratio for today is 76.11.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Rubicon Research's Enterprise Value is ₹236,674 Mil. Rubicon Research's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹13,357 Mil. Therefore, Rubicon Research's EV-to-Revenue ratio for today is 17.72.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Rubicon Research's Enterprise Value is ₹236,674 Mil. Rubicon Research's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹439 Mil. Therefore, Rubicon Research's EV-to-OCF ratio for today is 538.56.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Rubicon Research's Enterprise Value is ₹236,674 Mil. Rubicon Research's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-994 Mil. Therefore, Rubicon Research's EV-to-FCF ratio for today is -238.04.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Rubicon Research  (NSE:RUBICON) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Rubicon Research's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=236673.895/2775.7
=85.27

Rubicon Research's current Enterprise Value is ₹236,674 Mil.
Rubicon Research's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,776 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Rubicon Research's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=236673.895/3109.58
=76.11

Rubicon Research's current Enterprise Value is ₹236,674 Mil.
Rubicon Research's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,110 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Rubicon Research's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=236673.895/13357.01
=17.72

Rubicon Research's current Enterprise Value is ₹236,674 Mil.
Rubicon Research's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹13,357 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Rubicon Research's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=236673.895/439.46
=538.56

Rubicon Research's current Enterprise Value is ₹236,674 Mil.
Rubicon Research's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹439 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Rubicon Research's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=236673.895/-994.26
=-238.04

Rubicon Research's current Enterprise Value is ₹236,674 Mil.
Rubicon Research's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-994 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rubicon Research Enterprise Value Related Terms


Rubicon Research Enterprise Value Historical Data

* Premium members only.

The historical data trend for Rubicon Research's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rubicon Research Enterprise Value Chart

Rubicon Research Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Enterprise Value
0.00 0.00 0.00 126,818.15

Rubicon Research Quarterly Data
Mar23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial 0.00 0.00 0.00 112,153.56 126,818.15

NSE:RUBICON vs LLY, JNJ, ABBV: Enterprise Value Comparison

For the Drug Manufacturers - General subindustry, Rubicon Research's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rubicon Research Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rubicon Research's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Rubicon Research's Enterprise Value falls into.


NSE:RUBICON
18GF Score
Rubicon Research Ltd NSE:RUBICON
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rubicon Research Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Rubicon Research's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as

Rubicon Research's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of ₹236,674 Mil mean?
Rubicon Research (NSE:RUBICON) has a Enterprise Value of ₹236,674 Mil as of Jul. 19, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rubicon Research and its competitors.
Is Rubicon Research's Enterprise Value too high?
Rubicon Research's current Enterprise Value is ₹236,674 Mil. Overall, Rubicon Research has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Rubicon Research's Enterprise Value compare to LLY and JNJ?
Rubicon Research's Enterprise Value of ₹236,674 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rubicon Research and its competitors. Rubicon Research's current Enterprise Value is ₹236,674 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Research stock overvalued right now?
Rubicon Research (NSE:RUBICON) has a current Enterprise Value of ₹236,674 Mil. The current Enterprise Value is ₹236,674 Mil. Rubicon Research's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Rubicon Research (NSE:RUBICON), the current Enterprise Value is ₹236,674 Mil as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rubicon Research Business Description

Other Exchanges 544578:India
Address Road No. 33, MedOne House, B-75, Wagle Estate, Thane West, Thane, MH, IND, 400 604
Rubicon Research Ltd is a pharmaceutical formulations company specializing in developing, manufacturing, and marketing branded specialty and generic prescription products. Starting as a provider of contract formulation development services, the company expanded to operate an oral solids manufacturing facility in India, offering contract development and manufacturing services for regulated markets. The company's diverse product portfolio covers multiple therapeutic areas, including analgesics and pain management, CVS, CNS, hypokalemia, skeletal muscle relaxants, NRT, gastrointestinal, metabolic, and immunosuppressants. The company operates in India, the USA, and other markets, with the majority of its revenue coming from the USA.
18GF Score

Get the complete analysis for NSE:RUBICON

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,439.60
Price